<div id="readability-page-1">Long Beach Medical Center's MemorialCare Heart &amp; Vascular Institute, situated in Long Beach, California, is among just two locations in the state taking part in the worldwide RESPONDER HF trial. This trial is focused on assessing the effectiveness of the Corvia® Atrial Shunt in individuals struggling with heart failure. The news was announced on February 11, 2026.</div>

159570

516930

512010

<p>Long Beach Medical Center's MemorialCare Heart & Vascular Institute, situated in Long Beach, California, is among just two locations in the state taking part in the worldwide RESPONDER HF trial. This trial is focused on assessing the effectiveness of the Corvia® Atrial Shunt in individuals struggling with heart failure. The news was announced on February 11, 2026.</p>

Unusual Whales

China Universal CNI HK Connect Innovative Drugs Industry ETF

Minsheng Royal CSI Biotechnology Theme ETF

E Fund CSI 300 Health Care ETF

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

Bosera Hang Seng SCHK Innovative Drug Select ETF

ChinaAMC Hang Seng Biotechnology Technology ETF(QDII)

China Merchants CSI Biotechnology Theme ETF

Direxion S&P Biotech Bull 3X

E Fund CSI Biotechnology Theme ETF

E Fund Hang Seng SCHK Innovative Drug ETF

VanEck Biotech ETF

Guotai CSI Bio-medicine ETF

iShares US Pharma

Health Care Select Sector SPDR

First Trust NYSE Arca Biotech Index Fd

ChinaAMC SSE STAR Biology and Medicine ETF

ALPS Medical Breakthrough

Yinhua CSI Innovative Drugs Industry ETF

Ark Genomic Revolution ETF

iShares Biotechnology ETF

ChinaAMC SSE Health Care ETF Initiating Fund

ChinaAMC CSI Biotechnology Theme ETF

Invesco Biotechnology & Genome ETF

Proshares Ultra Nasdaq Biotech

iShares Global Healthcare

SPDR S&P Biotech

Proshares UltraShort Nasdaq Biotech

VG Health

Long Beach Medical Center joins global trial of Corvia® Atrial Shunt for heart failure patients in 2026. #HFpEF #heartfailure